Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevascar intradermal administration for scar improvement in subjects of African Continental ancestry
2009-017400-91Phase 2Completed
- Sponsor
- Renovo
- Start
- Jun 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of interleukin 10 in hypertrophic scar (5 arms), sponsored by Renovo. Primary endpoint: Primary scar improvement at 12 months post excision surgery. Started Jun 2010; status: completed.
02
Drugs
interleukin 10
03
Conditions
hypertrophic scar
Beyond the preview
Go deeper on 2009-017400-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017400-91.